Global Allergy Immunotherapies Market 2019-2023 - Product Image

Global Allergy Immunotherapies Market 2019-2023

  • ID: 4703285
  • Report
  • Region: Global
  • 113 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer
  • MORE
The emerging drug development technologies is likely to help the market grow during the forecast period. The recent advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more efficient immunotherapies for the treatment of various allergies. Analysts have predicted that the allergy immunotherapies market will register a CAGR of more than 7% by 2023.

Market Overview

Increasing prevalence of various types of allergies

The increasing prevalence of various types of allergies across the globe is driving the allergy immunotherapies market. The growing occurrence of allergy is generated by the factors such as increasing pollution and augmented consumption of tobacco products like cigarettes, which is likely to boost the global allergy immunotherapy market.

Unknown pathogenesis

The Unknown pathogenesis of various allergies is the major challenge faced by the global allergy immunotherapies market. The unclear cause of allergy results in physicians misdiagnosing the allergen, and as a result the treatment prescribed is not as effective as it should be, and it often leads to adverse events.

For the detailed list of factors that will drive and challenge the growth of the allergy immunotherapies market during the 2019-2023, view the report.

Competitive Landscape

The market appears to be concentrated and with the presence of few companies including ALK and Allergy Therapeutics the competitive environment is quite intense. Factors such as the emerging drug development technologies and the technological advances in allergy diagnostics, will provide considerable growth opportunities to allergy immunotherapies manufactures. ALK, Allergy Therapeutics, Stallergenes Greer, HAL Allergy, and Merck are some of the major companies covered in this report.

‘With the presence of a considerable number of companies, this market appears to be fragmented. The current advances in the immunotherapy drug development are helping the pharmaceutical companies to develop more effective immunotherapies for the treatment of various allergies. Several established allergy immunotherapy manufacturers are striving for their share of the global allergy immunotherapies market, and the new players must differentiate themselves to gain vital traction over their competitors.’
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
  • PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
A. PIPELINE

PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • SCIT - Market size and forecast 2018-2023
  • SLIT - Market size and forecast 2018-2023
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • EMEA - Market size and forecast 2018-2023
  • Americas - Market size and forecast 2018-2023
  • APAC - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS

PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
List of Exhibits
Exhibit 01: Global immunology treatment market
Exhibit 02: Segments of global immunology treatment market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Global allergy immunotherapies market: Overview
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Global allergy immunotherapies market pipeline: Overview
Exhibit 19: Global allergy immunotherapies market pipeline: Overview
Exhibit 20: Product - Market share 2018-2023 (%)
Exhibit 21: Comparison by product
Exhibit 22: SCIT - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: SCIT - Year-over-year growth 2019-2023 (%)
Exhibit 24: Opportunity analysis of global SCIT market
Exhibit 25: SLIT - Market size and forecast 2018-2023 ($ millions)
Exhibit 26: SLIT - Year-over-year growth 2019-2023 (%)
Exhibit 27: Opportunity analysis of global SLIT market
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: EMEA - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: EMEA - Year-over-year growth 2019-2023 (%)
Exhibit 34: Americas - Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Americas - Year-over-year growth 2019-2023 (%)
Exhibit 36: APAC - Market size and forecast 2018-2023 ($ millions)
Exhibit 37: APAC - Year-over-year growth 2019-2023 (%)
Exhibit 38: Key leading countries
Exhibit 39: Market opportunity
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Geographical presence of few prominent vendors 2018
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: ALK - Vendor overview
Exhibit 48: ALK - Business segments
Exhibit 49: ALK - Organizational developments
Exhibit 50: ALK - Geographic focus
Exhibit 51: ALK - Key offerings
Exhibit 52: ALK - Key customers
Exhibit 53: Allergy Therapeutics - Vendor overview
Exhibit 54: Allergy Therapeutics - Business segments
Exhibit 55: Allergy Therapeutics - Organizational developments
Exhibit 56: Allergy Therapeutics - Segment focus
Exhibit 57: Allergy Therapeutics - Key offerings
Exhibit 58: Allergy Therapeutics - Key customers
Exhibit 59: HAL Allergy - Vendor overview
Exhibit 60: HAL Allergy - Business segments
Exhibit 61: HAL Allergy - Organizational developments
Exhibit 62: HAL Allergy - Key offerings
Exhibit 63: HAL Allergy - Key customers
Exhibit 64: Merck - Vendor overview
Exhibit 65: Merck - Business segments
Exhibit 66: Merck - Organizational developments
Exhibit 67: Merck - Geographic focus
Exhibit 68: Merck - Segment focus
Exhibit 69: Merck - Key offerings
Exhibit 70: Merck - Key customers
Exhibit 71: Stallergenes Greer - Vendor overview
Exhibit 72: Stallergenes Greer - Business segments
Exhibit 73: Stallergenes Greer - Organizational developments
Exhibit 74: Stallergenes Greer - Geographic focus
Exhibit 75: Stallergenes Greer - Key offerings
Exhibit 76: Stallergenes Greer - Key customers
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer
  • MORE
The author of the report recognizes the following companies as the key players in the global allergy immunotherapies market: ALK, Allergy Therapeutics, Stallergenes Greer, HAL Allergy, and Merck.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the emerging drug development technologies.”

According to the report, one of the major drivers for this market is the increasing prevalence of various types of allergies.

Further, the report states that one of the major factors hindering the growth of this market is the unknown pathogenesis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll